South Carolina Fosamax Injury Lawyer Fighting For Injury Victims
First approved and released onto the market in 1995, Fosamax is a bisphosphonate that has a long history of FDA investigations, warnings and disturbing side effects. Manufactured by pharmaceutical giant Merck & Co., it is touted as a bone-strengthening medication to treat osteoporosis, Paget’s disease and other bone-related disorders. The truly disturbing aspect of this alleged dangerous drug is that studies have shown it may have the opposite effects on patients, linking it to bone deterioration and other severe side effects. Patients harmed by Fosamax need drug injury attorneys to hold the manufacturer accountable for its negligent actions and misrepresentations regarding the drug’s effectiveness and safety.
Fosamax Warning for Osteonecrosis of the Jaw (ONJ)
In 2004, the FDA required a label on Fosamax and other bisphosphonates to warn patients of the risk of osteonecrosis of the jaw (ONJ), also called Dead Jaw Syndrome. This debilitating disease completely destroys the jaw bone and may require extensive reconstructive surgeries. Early indicators of ONJ include dental trauma and infections of the mouth.
Since 2001, there have been over 2,000 patients who have developed ONJ, and the Journal of Oral and Maxillofacial Surgeons recently published a study concluding that side effects of Fosamax include ONJ.
Additional Fosamax Side Effects are Severe
Fosamax and bisphosphonates have been under scrutiny by the FDA since their release onto the market, and the many severe side effects evidence that Fosamax is a dangerous drug:
- In 2007, the FDA looked into claims that Fosamax caused irregular heartbeat and atrial fibrillation. It cited a study by the New England Journal of Medicine that described an increased risk of atrial fibrillation for older women with osteoporosis while taking bisphosphonates. The FDA continues to monitor these studies and reports from patients.
- In 2008, the FDA noted that some patients experience severe and sometimes incapacitating musculoskeletal pain while taking bisphosphonates, including Fosamax. The pain may occur immediately or years after taking the drug and is characterized by fever, chills, bone pain, myalgias (muscle pain) and arthralgias (joint pain).
- In 2010, the FDA released a safety notice for patients with osteoporosis that unusual femur fractures have been predominantly reported in patients taking bisphosphonates, including Fosamax. This information must now be included on the drug label.
- In 2011, studies are being reviewed by the FDA to evaluate whether Fosamax is associated with an increased risk of cancer of the esophagus.
Fosamax Lawsuits are Currently Ongoing
While there has not yet been an FDA drug recall issued, a Fosamax recall is unnecessary to bring a successful lawsuit by a Fosamax lawyer if you have suffered an injury or disease because of this drug. Individuals may be entitled to compensation, including payment for medical bills, lost wages, pain and suffering and more. There is currently multi district litigation ongoing regarding Fosamax, and victims may be able to join the current litigation or file a separate lawsuit. Contact our Fosamax attorneys for a consultation to learn more about the options available to you.